Otsuka Pharmaceutical Co., Ltd.’s $250 million acquisition of Neurovance, Inc.

Ambrogio Visconti

McDermott Will & Emery acted as legal adviser to Neurovance, Inc. in its acquisition by a major Japanese pharmaceutical company Otsuka Pharmaceutical Co., Ltd. (OPC). Under…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now